NOV 23, 2019 11:13 PM PST

Drug Seeks To Target Treatment-Resistant Epilepsy

WRITTEN BY: Nouran Amin

Ever imagined a world where you cannot shower alone, drive by yourself, and even go to work in fear of having the next seizure that can incapacitate you? Unfortunately, this is the life of many patients with epilepsy—a chronic seizure condition. To bring hope, researchers at John Hopkins University found that an investigational drug called ‘cenobamate’ can reduce seizures by 55%.

Although there exists more than 20 anti-seizure drugs on the market, approximately half of epilepsy patients don’t become seizure-free on these medications. Cenobamate, which is not yet approved by the Food and Drug Administration (FDA), aims to target treatment-resistant epilepsy. In order for cenobamate to be approved, it must be safely administered and evaluated in 30,000 epileptic patients

“A quarter of the patients I treat with this drug [cenobamate] who were disabled by frequent partial-onset (focal) seizures now have been seizure-free for several years,” says lead investigator Gregory Krauss, M.D., professor of neurology at the Johns Hopkins University School of Medicine. “It is wonderful to see the improvement in many of my patients’ lives. They have improved confidence and can live more normal lives. Many can now work, and both patients and caretakers can be more independent.”

Learn more about epilepsy:

In the study, regular treatment was stimulated and clinical participants were given 100, 200 or 400 milligrams of cenobamate or a placebo pill with the cenobamate dose increasing for up to six weeks until the desired testing dose was reached. However, to meet FDA ethical standards, participants must remain on their regularly prescribed anti-seizure medication.

Findings of the study were published in The Lancet Neurology.

Source: Hopkins Medicine

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
OCT 03, 2020
Cannabis Sciences
Cannabis Compound Prevents Colon Cancer in Mice
OCT 03, 2020
Cannabis Compound Prevents Colon Cancer in Mice
Second only to skin cancer, colon cancer is the most common cancer diagnosed in both men and women in the US. Now, resea ...
OCT 29, 2020
Drug Discovery & Development
Scientists Create Antibiotic from Komodo Dragon Blood
OCT 29, 2020
Scientists Create Antibiotic from Komodo Dragon Blood
Researchers from George Mason University in Washington DC have created a synthetic molecule from Komodo Dragon blood tha ...
NOV 24, 2020
Drug Discovery & Development
MMR Vaccine Shows Promise Against COVID-19
NOV 24, 2020
MMR Vaccine Shows Promise Against COVID-19
Researchers have found that a vaccine used for mumps, measles, and rubella (MMR) may be effective in protecting against ...
NOV 18, 2020
Drug Discovery & Development
Hepatitis C Drugs May Be Involved Coronavirus Treatment
NOV 18, 2020
Hepatitis C Drugs May Be Involved Coronavirus Treatment
At the present moment, there are no inhibitors that target protease activity of the novel SARS-CoV-2. The main proteases ...
NOV 26, 2020
Cannabis Sciences
Women More Likely than Men to Swap Prescription Medication for Cannabis
NOV 26, 2020
Women More Likely than Men to Swap Prescription Medication for Cannabis
The stigma around cannabis usage is fading as cannabis laws become increasingly lax. Now, researchers from DePaul Univer ...
NOV 26, 2020
Drug Discovery & Development
Sestrin Increases the Lifespan of Fruit Flies
NOV 26, 2020
Sestrin Increases the Lifespan of Fruit Flies
Reduced food intake, known as dietary restriction, leads to a longer lifespan in many animals and can improve health in ...
Loading Comments...